U.S. IS LAGGING IN TESTING AND WHY HE SAYS HE’S OPTIMISTIC
WHY HE SAYS HE’S OPTIMISTIC ABOUT THE TIMELINE FOR A
ABOUT THE TIMELINE FOR A VACCINE.
VACCINE. >> THE GATES FOUNDATION IS VERY
>> THE GATES FOUNDATION IS VERY MUCH AT THE FOREFRONT ON THIS
MUCH AT THE FOREFRONT ON THIS HUNT FOR A VACCINE.
HUNT FOR A VACCINE. WE’VE ALL LEARNED BY NOW THE
WE’VE ALL LEARNED BY NOW THE TIMELINE, THE HOPEFUL TIMELINE
TIMELINE, THE HOPEFUL TIMELINE OF 12 TO 18 MONTHS.
OF 12 TO 18 MONTHS. THAT IS A HIGHLY EXPEDITED
THAT IS A HIGHLY EXPEDITED TRACK, A FAST TRACK FOR A
TRACK, A FAST TRACK FOR A VACCINE.
VACCINE. CAN YOU EXPLAIN WHY?
CAN YOU EXPLAIN WHY? >> FOR MOST DISEASES, YOU DON’T
>> FOR MOST DISEASES, YOU DON’T PURSUE MORE THAN ONE OR TWO
PURSUE MORE THAN ONE OR TWO APPROACHES.
APPROACHES. HERE BECAUSE OF ALL THE
HERE BECAUSE OF ALL THE INCREDIBLY NEGATIVE EFFECTS, THE
INCREDIBLY NEGATIVE EFFECTS, THE SOONER THE BETTER AND SO WE’RE
SOONER THE BETTER AND SO WE’RE GOING TO PURSUE.
GOING TO PURSUE. THERE ARE 100 EFFORTS THAT MAYBE
THERE ARE 100 EFFORTS THAT MAYBE TEN OF THOSE SHOULD GET THE
TEN OF THOSE SHOULD GET THE RESOURCES TO BUILD FACTORIES AND
RESOURCES TO BUILD FACTORIES AND GO FULL SPEED AHEAD AND IT WILL
GO FULL SPEED AHEAD AND IT WILL BE MULTIPLE COMPANIES, WHICH
BE MULTIPLE COMPANIES, WHICH THAT’S NOT TYPICAL AND IT WILL
THAT’S NOT TYPICAL AND IT WILL BE AT RISK BECAUSE THOSE ARE
BE AT RISK BECAUSE THOSE ARE BILLIONS OF DOLLARS THAT WHEN
BILLIONS OF DOLLARS THAT WHEN THEY’RE SUCCESSFUL WILL SAVE
THEY’RE SUCCESSFUL WILL SAVE TRILLIONS OF DOLLARS OF BROAD
TRILLIONS OF DOLLARS OF BROAD DAMAGE SO THE BEST SCIENTISTS
DAMAGE SO THE BEST SCIENTISTS WORKING HARD ON THIS AND I’M
WORKING HARD ON THIS AND I’M HOPEFUL.
HOPEFUL. IN FACT, IN THE LAST FEW WEEKS
IN FACT, IN THE LAST FEW WEEKS I’VE SEEN SIGNS THAT WE MAY GET
I’VE SEEN SIGNS THAT WE MAY GET TO THE OPTIMISTIC SIDE OF THAT
TO THE OPTIMISTIC SIDE OF THAT TIME PROJECTION.
TIME PROJECTION. >> WHAT ABOUT TREATMENTS?
>> WHAT ABOUT TREATMENTS? THAT’S -- YOU SAID IF WE COULD
THAT’S -- YOU SAID IF WE COULD GET A MIRACLE DRUG, A MIRACLE
GET A MIRACLE DRUG, A MIRACLE TREATMENT THAT WOULD, YOU KNOW,
TREATMENT THAT WOULD, YOU KNOW, TAKE CARE OF IT FOR 95% OF
TAKE CARE OF IT FOR 95% OF PEOPLE, MAYBE WE COULD ALL BE AT
PEOPLE, MAYBE WE COULD ALL BE AT THE BASEBALL GAME NEXT SPRING.
THE BASEBALL GAME NEXT SPRING. YOU SAID YOU DON’T THINK THAT’S
YOU SAID YOU DON’T THINK THAT’S LIKELY BUT WHERE IS THE HOPE ON
LIKELY BUT WHERE IS THE HOPE ON THE TREATMENT TRACK?
THE TREATMENT TRACK? >> WELL, THERE’S A HUGE NUMBER
>> WELL, THERE’S A HUGE NUMBER OF COMPOUNDING BEING TRIED.
OF COMPOUNDING BEING TRIED. THE PUBLIC KNOWS ABOUT
THE PUBLIC KNOWS ABOUT REMDESIVIR
REMDESIVIR REMDESIVIR, HYDROXYCHLOROQUINE,
REMDESIVIR, HYDROXYCHLOROQUINE, YOU KNOW, WHENEVER ONE IT IS,
YOU KNOW, WHENEVER ONE IT IS, MOST WILL FAIL BUT A FEW I THINK
MOST WILL FAIL BUT A FEW I THINK WILL HAVE SUBSTANTIAL EFFECTS.
WILL HAVE SUBSTANTIAL EFFECTS. AS FAR AS I KNOW, NONE OF THE
AS FAR AS I KNOW, NONE OF THE TRIALS HAVE HAD THAT KIND OF,
TRIALS HAVE HAD THAT KIND OF, YOU KNOW, AMAZING RESULT WHERE
YOU KNOW, AMAZING RESULT WHERE YOU STOP IT EARLY AND GO HEY, WE
YOU STOP IT EARLY AND GO HEY, WE HAVE TO GET THIS OUT.
HAVE TO GET THIS OUT. SO, YOU KNOW, EVEN IF THOSE LEAD
SO, YOU KNOW, EVEN IF THOSE LEAD COMPOUNDS DO NOT HAVE
COMPOUNDS DO NOT HAVE SIGNIFICANT BENEFIT, BELIEVE ME,
SIGNIFICANT BENEFIT, BELIEVE ME, THERE IS SO MANY GOOD IDEAS THAT
THERE IS SO MANY GOOD IDEAS THAT SOME WILL.
SOME WILL. SO NO ONE SHOULD PUT THEIR HOPE
SO NO ONE SHOULD PUT THEIR HOPE BEHIND A PARTICULAR APPROACH AND
BEHIND A PARTICULAR APPROACH AND HYDROXY MAY HAVE A MODEST
HYDROXY MAY HAVE A MODEST EFFECT.
EFFECT. BY THE END OF MAY WILL BE CLEAR.
BY THE END OF MAY WILL BE CLEAR. >> I THINK IF THERE IS ANY AREA
>> I THINK IF THERE IS ANY AREA THAT SEEMS TO HAVE BEEN
THAT SEEMS TO HAVE BEEN BEDELVING DURING THIS CRISIS,
BEDELVING DURING THIS CRISIS, IT’S TESTING.
IT’S TESTING. I WONDER HOW YOU ASSESS HOW THE
I WONDER HOW YOU ASSESS HOW THE U.S. HAS DONE IN TESTING AND
U.S. HAS DONE IN TESTING AND WHAT SEEMS TO BE THE ISSUE HERE?
WHAT SEEMS TO BE THE ISSUE HERE? WHAT’S THE BREAKDOWN?
WHAT’S THE BREAKDOWN? WHAT’S THE PROBLEM?
WHAT’S THE PROBLEM? SHOULD HAVE BEEN BETTER?
SHOULD HAVE BEEN BETTER? >> WELL, MANY COUNTRIES DECIDED
>> WELL, MANY COUNTRIES DECIDED THAT AT THE NATIONAL LEVEL THEY
THAT AT THE NATIONAL LEVEL THEY WOULD ORCHESTRATE THE TESTING
WOULD ORCHESTRATE THE TESTING AND, YOU KNOW, DO THAT VERY
AND, YOU KNOW, DO THAT VERY EARLY SO ALL OF THESE MACHINES
EARLY SO ALL OF THESE MACHINES CALLED PCR MACHINES WOULD BE
CALLED PCR MACHINES WOULD BE USED 24 HOURS A DAY AND YOU
USED 24 HOURS A DAY AND YOU WOULD BE TESTING THE RIGHT
WOULD BE TESTING THE RIGHT PEOPLE.
PEOPLE. THAT HASN’T HAPPENED IN THE
THAT HASN’T HAPPENED IN THE UNITED STATES.
UNITED STATES. IT MIGHT NOT HAPPEN.
IT MIGHT NOT HAPPEN. BUT, YOU KNOW, THE ACCESS TO
BUT, YOU KNOW, THE ACCESS TO TESTS IS JUST, YOU ME, CHAOTIC.
TESTS IS JUST, YOU ME, CHAOTIC. IF YOU’RE A LOW INCOME PERSON,
IF YOU’RE A LOW INCOME PERSON, YOUR ACCESS IS LESS THAN A HIGH
YOUR ACCESS IS LESS THAN A HIGH INCOME PERSON.
INCOME PERSON. WE SHOULD FOCUS ON THE
WE SHOULD FOCUS ON THE SYMPTOMATICS AND THE CONTACT
SYMPTOMATICS AND THE CONTACT TRACING.
TRACING. SO I DON’T KNOW WHETHER THIS
SO I DON’T KNOW WHETHER THIS WILL GET ORGANIZED.
WILL GET ORGANIZED. THE CAPACITY IS GOING UP BUT,
THE CAPACITY IS GOING UP BUT, YOU KNOW, WHEN YOU GET THE
YOU KNOW, WHEN YOU GET THE RESULTS LATE, IT’S ALMOST
RESULTS LATE, IT’S ALMOST WORTHLESS AND SO WE CAN’T
WORTHLESS AND SO WE CAN’T IMPROVE A NUMBER OF INVASIONS
IMPROVE A NUMBER OF INVASIONS HAVE BEEN DRIVEN.
HAVE BEEN DRIVEN. WE WERE INVOLVED IN PROBLEMINGAT
